Article
Fate of recombinant adeno-associated viral vector genomes during DNA double-strand break-induced gene targeting in human cells.
Human gene therapy - 1 May 2010
Gellhaus Katharina, Cornu Tatjana I, Heilbronn Regine, Cathomen Toni
Abstract excerpt
Recombinant vectors based on adeno-associated virus (rAAV) are promising tools to specifically alter complex genomes through homologous recombination (HR)-based gene targeting. In a therapeutic setting, an AAV donor vector will recombine with a mutant target locus in order to correct the mutation directly in the genome. The low frequency of HR in mammalian cells can be significantly improved by insertion of a DNA...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
